Han Ah on Muck Rack

Han Ah

As seen in: MDPI, Biomed Central (BMC)
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Han

Contact Han, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Effect of 12-week intermittent calorie restriction compared to standard of care in patients with nonalcoholic fatty liver disease: a randomized controlled trial | Trials | Full Text

|
By Han Ah, Hye Ah, Hwi Young, Ewha Womans
| Biomed Central (BMC)
Study setting The study will recruit 72 patients who will be followed up actively according to the protocol for 24 weeks. Patients will be classified according to their BMI (obese group: BMI ≥ 25 kg/m2 [36 patients] and non-obese group: BMI < 25 kg/m2 [36 patients]). An enrollment period of 12 months is expected. Eligibility criteria The following are the inclusion criteria: 1.
Open in Who Shared Issue with article?

Therapeutic Mechanisms and Clinical Effects of Glucagon-like Peptide 1 Receptor Agonists in Nonalcoholic Fatty Liver Disease

|
By Han Lee, Hwi Young Kim, Han Ah, Hwi Young
| MDPI
Author / Affiliation / Email Search Type Submit to this Journal Review for this Journal Edit a Special Issue Article Menu /ajax/scifeed/subscribe Altmetric share Share announcement Help format_quote Cite thumb_up ... Endorse textsms ... Comment Need Help? Support Find support for a specific problem in the support section of our website. Get Support Feedback Please let us know what you think of our products and services.
Open in Who Shared Issue with article?

Effect of 12-week intermittent calorie restriction compared to standard of care in patients with nonalcoholic fatty liver disease: a randomized controlled trial (pdf) | Paperity

|
By Han Ah, Hye Ah, Hwi Young
| paperity.org
Trials, Aug 2023 Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease. NAFLD can result in various complications. Owing to the lack of effective pharmacological therapies, lifestyle modifications are the cornerstone treatment for NAFLD. However, there has been no recommendation for a specific dietary therapy. Because no significant effects have been observed in previous studies.
Open in Who Shared Issue with article?
See all 3 articles
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified